Ginkgo Bioworks (DNA) announced it has been awarded by the Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory a four-year, up to $47M contract to co-design, build, and integrate a High-Throughput Automated Phenotyping Platform in support of the Microbial Molecular Phenotyping Capability. The platform, selected through a competitive procurement process, is intended to enable the Department of Energy’s Office of Science, Biological and Environmental Research program to generate rich, reproducible microbial and microbiome data that ensure the U.S. remains at the forefront of the bioeconomy, safeguarding economic, societal, and national security benefits while maintaining global leadership in biotechnology innovation.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNA:
- Private Markets: Prediction market platform Kalshi secures $300M
- Private Markets: Anthropic to invest $50B in computing infrastructure
- Ginkgo Bioworks Earnings Call: Mixed Sentiments and Strategic Moves
- Ginkgo Bioworks Reports Q3 2025 Financial Results
- Ginkgo Bioworks Holdings: Strategic Growth Amid Revenue Decline Justifies Buy Rating
